LXR α Antibodies

Santa Cruz Biotechnology offers a broad range of LXR α Antibodies for research in lipid metabolism and cholesterol homeostasis. LXR α Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Liver X Receptor alpha (LXR α) plays a crucial role in regulating the expression of genes involved in lipid metabolism, inflammation, and glucose homeostasis. LXR α activation enables researchers to investigate its impact on atherosclerosis, metabolic syndrome, and other related diseases. Understanding LXR α function is essential for uncovering molecular mechanisms underlying lipid regulation and its implications for human health. Research focused on LXR α continues to reveal new insights into metabolic disorders and potential therapeutic approaches. Investigating LXR α pathways helps advance our understanding of cellular responses to metabolic stress and inflammation. LXR α research contributes significantly to developing new treatment strategies for metabolic diseases. Santa Cruz Biotechnology monoclonal antibodies for LXR α support researchers worldwide in advancing scientific understanding of metabolic regulation and disease mechanisms.